mAbxience
mAbxience is a biosimilar Monoclonal antibodies founded in 2010.
Overview
mAbxience is a biosimilar Monoclonal antibodies founded in 2010.
-
Website:
- Business model: B2B
- Social accounts:
Industries
mAbxience is active in the following industries: